Vapogenix
vapogenix.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$11.9M
3 rounds on record
Latest round
$1.6M
Venture round · Dec 2017 · 8 yr ago
Team
11-50
employees, estimated range
Backers
1
IrishAngels
The money's age
Long since its last round
105 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 29, 2017
Raised a round Venture round $1.6M · SEC Form D
Aug 31, 2016
Raised a round Venture round $8.2M · SEC Form D
Dec 23, 2014
Raised a round Venture round $2.1M · MedCity News
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2017 | $1.6M | — | SEC Form D |
| Venture round | Aug 2016 | $8.2M | — | SEC Form D |
| Venture round | Dec 2014 | $2.1M | — | MedCity News |
Registers and programsofficial lists and records that name the company
| Legal entity | Vapogenix, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Danguole AltmanExecutive Officer, DirectorSEC Form D
Motter ClariceExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
IrishAngels Similar startupsby what they do, their industry and backers
Revolutionizing acute pain management. Rebel is focused on developing disruptive, non-opioid solutions for acute pain.
Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…
Draupnir Bio is developing new innovative therapies for patients.
Nivaan Care is India's most advanced non-surgical pain management clinic, treating back, neck, knee & shoulder pain with expert doctors &…
Relevium Medical develops innovative injectable hydrogel therapeutics targeting chronic pain and urology disorders for long-lasting relief…
Real-time Global Container Tracking and Monitoring Made Simple. Long-lasting sensors that deliver control for decades. Nordic technology.
Overview
A Breakthrough in Non-Opioid Pain Management. Vapogenix is developing non-opioid, rapid-onset, long-lasting pain therapies.
News
Vapogenix Awarded $1.5M Phase II SBIR Grant to Develop Groundbreaking Topical Therapy for Painful Inflammatory Conditions
Houston's Vapogenix awarded $1.5 M Phase II SBIR grant to develop new, unique topical pain therapy. Will seek IND to progress to clinical studies.
Read more
Report
Vapogenix, Developing Non-Opioid Pain Alternatives, Meeting with Investors, Partners During JP Morgan Healthcare Conference Week
Read more
Report
Vapogenix gets $2.1M for topical, localized, non-narcotic pain med
Vapogenix, a Houston pain medicine startup that's developing a localized analgesic that penetrates the skin quickly, just raised a tidy sum - $2.1 million, according to a regulatory filing. The company won't say which small molecule drug it's working with
Read more
Report
People
Danguole Altman
Executive Officer, Director
Motter Clarice
Executive Officer
George Davitt
Director
Christopher Jorgensen
Director
Marc Loev
Director
Bruce Given
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston
United States
HQ
10-50 est. staff